10/3 podcast: Why a COVID-19 vaccine is a moral responsibility

Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020. Picture taken on March 12, 2020. Andreas Gebert / Reuters

Share Adjust Comment Print

There is a race on for effective treatments for COVID-19.

Old malaria drugs that may or may not work are being held up as possible treatments.

Researchers are busy trying to develop a vaccine, work which is all the more important after a SARS vaccine was abandoned.

Guest host Monique Beaudin is joined by National Post health reporter Sharon Kirkey.

Subscribe to 10/3 on your favourite podcast app.

Comments